CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: antimonite
Accession: CHEBI:30297
browse the term
Definition: A trivalent inorganic anion obtained by removal of all three protons from antimonous acid.
Synonyms: exact_synonym: trioxidoantimonate(3-); trioxoantimonate(3-); trioxoantimonate(III)
related_synonym: Formula=O3Sb; InChI=1S/3O.Sb/q3*-1;; InChIKey=JXYAODGLKNBUTA-UHFFFAOYSA-N; SMILES=[O-][Sb]([O-])[O-]; SbO3(3-)
xref_mesh: MESH:C061374
xref: PMID:17419726
cyclic_relationship: is_conjugate_base_of CHEBI:49870
G
Abcc2
ATP binding cassette subfamily C member 2
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of ABCC2 mRNA
CTD
PMID:32076005
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
G
Abcc3
ATP binding cassette subfamily C member 3
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of ABCC3 mRNA
CTD
PMID:32076005
NCBI chr10:79,296,681...79,342,749
Ensembl chr10:79,296,693...79,342,595
G
Akr1b10
aldo-keto reductase family 1 member B10
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of AKR1B10 mRNA
CTD
PMID:32076005
NCBI chr 4:63,038,459...63,060,336
Ensembl chr 4:63,040,169...63,053,852
G
Akr1c3
aldo-keto reductase family 1, member C3
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of AKR1C3 mRNA
CTD
PMID:32076005
NCBI chr17:66,110,970...66,127,867
Ensembl chr17:66,110,963...66,127,873
G
Aldh3a2
aldehyde dehydrogenase 3 family, member A2
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of ALDH3A2 mRNA
CTD
PMID:32076005
NCBI chr10:45,928,313...45,949,366
Ensembl chr10:45,908,524...45,949,281
G
Aldh3b2
aldehyde dehydrogenase 3 family, member B2
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of ALDH3B2 mRNA
CTD
PMID:32076005
NCBI chr 1:201,250,260...201,264,699
Ensembl chr 1:201,253,157...201,264,705 Ensembl chr 1:201,253,157...201,264,705
G
Aldh3b3
aldehyde dehydrogenase 3 family, member B3
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of ALDH3B2 mRNA
CTD
PMID:32076005
NCBI chr 1:201,193,832...201,201,666
Ensembl chr 1:201,187,962...201,250,204
G
Barx2
BARX homeobox 2
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of BARX2 mRNA
CTD
PMID:32076005
NCBI chr 8:30,251,132...30,319,105
Ensembl chr 8:30,251,132...30,319,013
G
Bmp4
bone morphogenetic protein 4
multiple interactions decreases expression
ISO
RTKI cpd inhibits the reaction [antimonite results in decreased expression of BMP4 mRNA]
CTD
PMID:17400267
NCBI chr15:19,618,538...19,633,494
Ensembl chr15:19,618,542...19,623,306
G
Btf3
basic transcription factor 3
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of BTF3 mRNA
CTD
PMID:32076005
NCBI chr 2:29,659,764...29,666,898
Ensembl chr 2:29,659,231...29,666,879 Ensembl chr13:29,659,231...29,666,879
G
Btg2
BTG anti-proliferation factor 2
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of BTG2 mRNA
CTD
PMID:32076005
NCBI chr13:45,531,881...45,535,642
Ensembl chr13:45,531,925...45,535,628
G
Calr
calreticulin
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of CALR mRNA
CTD
PMID:32076005
NCBI chr19:23,308,525...23,313,420
Ensembl chr19:23,308,351...23,313,414
G
Cbr1
carbonyl reductase 1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of CBR1 mRNA
CTD
PMID:32076005
NCBI chr11:32,860,571...32,862,981
Ensembl chr11:32,908,950...32,911,393 Ensembl chr11:32,908,950...32,911,393 Ensembl chr11:32,908,950...32,911,393
G
Cdkn2b
cyclin-dependent kinase inhibitor 2B
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of CDKN2B mRNA
CTD
PMID:32076005
NCBI chr 5:104,009,839...104,019,082
Ensembl chr 5:104,010,680...104,019,050
G
Cebpa
CCAAT/enhancer binding protein alpha
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of CEBPA mRNA
CTD
PMID:32076005
NCBI chr 1:87,759,631...87,762,303
Ensembl chr 1:87,759,433...87,762,412
G
Cnbp
CCHC-type zinc finger, nucleic acid binding protein
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of CNBP mRNA
CTD
PMID:32076005
NCBI chr 4:120,302,768...120,311,694
Ensembl chr 4:120,302,771...120,311,637
G
Cyp1b1
cytochrome P450, family 1, subfamily b, polypeptide 1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of CYP1B1 mRNA
CTD
PMID:32076005
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
G
Dhrs9
dehydrogenase/reductase 9
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of DHRS9 mRNA
CTD
PMID:32076005
NCBI chr 3:54,147,834...54,170,052
Ensembl chr 3:54,147,803...54,220,241
G
Dnajb1
DnaJ heat shock protein family (Hsp40) member B1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of DNAJB1 mRNA
CTD
PMID:32076005
NCBI chr19:24,522,731...24,526,419
Ensembl chr19:24,522,717...24,526,458
G
Dnajb4
DnaJ heat shock protein family (Hsp40) member B4
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of DNAJB4 mRNA
CTD
PMID:32076005
NCBI chr 2:241,129,346...241,159,272
Ensembl chr 2:241,130,340...241,159,089
G
Dsc1
desmocollin 1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of DSC1 mRNA; U 0126 inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of DSC1 mRNA]
CTD
PMID:32076005
NCBI chr18:11,499,936...11,556,801
Ensembl chr18:11,502,003...11,528,494
G
Dsg1
desmoglein 1
multiple interactions
ISO
2-tert-butyl-9-fluoro-3,6-dihydro-7H-benz(h)imidazo(4,5-f)isoquinoline-7-one promotes the reaction [[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of DSG1 mRNA]; [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of DSG1 mRNA; Hydrocortisone inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of DSG1 mRNA]; U 0126 inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of DSG1 mRNA]
CTD
PMID:32076005
NCBI chr18:11,674,687...11,705,383
Ensembl chr18:11,674,402...11,703,443
G
Egfr
epidermal growth factor receptor
increases expression
ISO
antimonite results in increased expression of EGFR protein
CTD
PMID:17400267
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
G
Egr3
early growth response 3
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of EGR3 mRNA
CTD
PMID:32076005
NCBI chr15:45,150,335...45,156,052
Ensembl chr15:45,150,567...45,154,627
G
Ehf
ets homologous factor
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of EHF mRNA
CTD
PMID:32076005
NCBI chr 3:89,639,845...89,680,061
Ensembl chr 3:89,641,833...89,679,997
G
Elf3
E74 like ETS transcription factor 3
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of ELF3 mRNA
CTD
PMID:32076005
NCBI chr13:46,690,460...46,695,394
Ensembl chr13:46,690,466...46,695,481
G
Epha1
Eph receptor A1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of EPHA1 protein
CTD
PMID:32076005
NCBI chr 4:71,246,409...71,260,920
Ensembl chr 4:71,246,409...71,260,846
G
Epha2
Eph receptor A2
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of EPHA2 protein
CTD
PMID:32076005
NCBI chr 5:153,605,644...153,634,115
Ensembl chr 5:153,605,644...153,634,117
G
Ephx1
epoxide hydrolase 1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of EPHX1 mRNA
CTD
PMID:32076005
NCBI chr13:92,714,315...92,744,105
Ensembl chr13:92,714,315...92,790,235
G
Fgfr3
fibroblast growth factor receptor 3
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of FGFR3 mRNA
CTD
PMID:32076005
NCBI chr14:76,987,242...77,002,671
Ensembl chr14:76,987,993...77,003,341
G
Flg
filaggrin
multiple interactions
ISO
2-tert-butyl-9-fluoro-3,6-dihydro-7H-benz(h)imidazo(4,5-f)isoquinoline-7-one promotes the reaction [[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of FLG mRNA]; [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of FLG mRNA; Hydrocortisone inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of FLG mRNA]; U 0126 inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of FLG mRNA]
CTD
PMID:32076005
NCBI chr 2:178,884,793...178,912,986
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of FOS mRNA
CTD
PMID:32076005
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
G
Foxq1
forkhead box Q1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of FOXQ1 mRNA
CTD
PMID:32076005
NCBI chr17:32,912,744...32,915,377
Ensembl chr17:32,912,744...32,915,377 Ensembl chr17:32,912,744...32,915,377
G
Fth1
ferritin heavy chain 1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of FTH1 mRNA
CTD
PMID:32076005
NCBI chr 1:206,627,142...206,629,430
Ensembl chr 1:206,627,103...206,725,424
G
Ftl1
ferritin light chain 1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of FTL mRNA
CTD
PMID:32076005
NCBI chr 1:95,936,387...95,938,234
Ensembl chr 1:95,936,387...95,939,725 Ensembl chr10:95,936,387...95,939,725 Ensembl chr 2:95,936,387...95,939,725
G
Gclc
glutamate-cysteine ligase, catalytic subunit
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of GCLC mRNA
CTD
PMID:32076005
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
G
Gclm
glutamate cysteine ligase, modifier subunit
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of GCLM mRNA
CTD
PMID:32076005
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
G
Ggt1
gamma-glutamyltransferase 1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of GGT1 mRNA
CTD
PMID:32076005
NCBI chr20:13,074,695...13,104,095
Ensembl chr20:13,074,700...13,108,442
G
Glrx
glutaredoxin
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of GLRX mRNA
CTD
PMID:32076005
NCBI chr 2:5,341,873...5,351,686
Ensembl chr 2:5,341,885...5,351,680
G
Gpx2
glutathione peroxidase 2
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of GPX2 mRNA
CTD
PMID:32076005
NCBI chr 6:95,493,589...95,496,877
Ensembl chr 6:95,493,589...95,496,877
G
Grhl1
grainyhead-like transcription factor 1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of GRHL1 mRNA
CTD
PMID:32076005
NCBI chr 6:41,207,325...41,257,516
Ensembl chr 6:41,207,348...41,254,301
G
Gsto1
glutathione S-transferase omega 1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of GSTO1 mRNA
CTD
PMID:32076005
NCBI chr 1:246,721,089...246,731,228
Ensembl chr 1:246,721,221...246,731,468
G
Hltf
helicase-like transcription factor
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of HLTF mRNA
CTD
PMID:32076005
NCBI chr 2:102,549,724...102,609,492
Ensembl chr 2:102,549,724...102,609,327
G
Hmox1
heme oxygenase 1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of HMOX1 mRNA
CTD
PMID:32076005
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Hopx
HOP homeobox
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of HOPX mRNA
CTD
PMID:32076005
NCBI chr14:31,055,912...31,082,909
Ensembl chr14:31,075,148...31,082,909
G
Hspa1a
heat shock protein family A (Hsp70) member 1A
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of HSPA1A mRNA
CTD
PMID:32076005
NCBI chr20:3,870,765...3,873,221
Ensembl chr20:3,856,006...3,873,227
G
Hspa8
heat shock protein family A (Hsp70) member 8
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of HSPA8 mRNA
CTD
PMID:32076005
NCBI chr 8:41,183,397...41,187,260
Ensembl chr 8:41,183,264...41,187,259
G
Hspb8
heat shock protein family B (small) member 8
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of HSPB8 mRNA
CTD
PMID:32076005
NCBI chr12:40,176,405...40,205,002
Ensembl chr12:40,176,532...40,191,185
G
Htatip2
HIV-1 Tat interactive protein 2
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of HTATIP2 mRNA
CTD
PMID:32076005
NCBI chr 1:99,473,411...99,488,632
Ensembl chr 1:99,469,245...99,488,629
G
Id1
inhibitor of DNA binding 1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of ID1 mRNA
CTD
PMID:32076005
NCBI chr 3:141,210,666...141,212,420
Ensembl chr 3:141,211,267...141,212,419
G
Ikzf2
IKAROS family zinc finger 2
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of IKZF2 mRNA
CTD
PMID:32076005
NCBI chr 9:71,046,038...71,191,296
Ensembl chr 9:71,042,440...71,190,867
G
Il1rn
interleukin 1 receptor antagonist
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of IL1RN mRNA
CTD
PMID:32076005
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
G
Ivl
involucrin
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of IVL mRNA
CTD
PMID:32076005
NCBI chr 2:178,146,694...178,160,807
Ensembl chr 2:178,147,061...178,149,100
G
Klf5
KLF transcription factor 5
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of KLF5 mRNA
CTD
PMID:32076005
NCBI chr15:76,060,320...76,079,445
Ensembl chr15:76,064,258...76,079,445
G
Krt1
keratin 1
multiple interactions
ISO
2-tert-butyl-9-fluoro-3,6-dihydro-7H-benz(h)imidazo(4,5-f)isoquinoline-7-one promotes the reaction [[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of KRT1 mRNA]; [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of KRT1 mRNA; Hydrocortisone inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of KRT1 mRNA]; U 0126 inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of KRT1 mRNA]
CTD
PMID:32076005
NCBI chr 7:132,976,618...132,981,844
Ensembl chr 7:132,976,620...132,981,844
G
Krt10
keratin 10
multiple interactions
ISO
2-tert-butyl-9-fluoro-3,6-dihydro-7H-benz(h)imidazo(4,5-f)isoquinoline-7-one promotes the reaction [[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of KRT10 mRNA]; [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of KRT10 mRNA; Hydrocortisone inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of KRT10 mRNA]; U 0126 inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of KRT10 mRNA]
CTD
PMID:32076005
NCBI chr10:84,338,695...84,343,279
Ensembl chr10:84,338,706...84,343,701
G
Loricrin
loricrin cornified envelope precursor protein
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of LORICRIN mRNA
CTD
PMID:32076005
NCBI chr 2:177,558,062...177,560,960
Ensembl chr 2:177,558,252...177,559,807
G
Maoa
monoamine oxidase A
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of MAOA mRNA
CTD
PMID:32076005
NCBI chr X:6,032,172...6,098,308
Ensembl chr X:6,030,795...6,099,593
G
Map2k1
mitogen activated protein kinase kinase 1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of MAP2K1 mRNA
CTD
PMID:32076005
NCBI chr 8:64,683,449...64,754,900
Ensembl chr 8:64,683,449...64,755,147
G
Mapk1
mitogen activated protein kinase 1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased phosphorylation of MAPK1 protein
CTD
PMID:32076005
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased phosphorylation of MAPK3 protein
CTD
PMID:32076005
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Mgst1
microsomal glutathione S-transferase 1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of MGST1 mRNA
CTD
PMID:32076005
NCBI chr 4:171,029,666...171,044,893
Ensembl chr 4:171,029,630...171,044,892
G
Mmp7
matrix metallopeptidase 7
increases expression multiple interactions
ISO
antimonite results in increased expression of MMP7 mRNA RTKI cpd inhibits the reaction [antimonite results in increased expression of MMP7 mRNA]
CTD
PMID:17400267
NCBI chr 8:4,848,186...4,855,908
Ensembl chr 8:4,848,186...4,855,902
G
Nfkb2
nuclear factor kappa B subunit 2
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of NFKB2 mRNA
CTD
PMID:32076005
NCBI chr 1:245,164,586...245,173,225
Ensembl chr 1:245,165,950...245,173,213
G
Nqo1
NAD(P)H quinone dehydrogenase 1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of NQO1 mRNA
CTD
PMID:32076005
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
Osm
oncostatin M
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] inhibits the reaction [OSM protein results in increased phosphorylation of STAT1 protein]
CTD
PMID:32076005
NCBI chr14:79,103,638...79,108,500
Ensembl chr14:79,104,344...79,108,313
G
Pbx1
PBX homeobox 1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of PBX1 mRNA
CTD
PMID:32076005
NCBI chr13:80,278,766...80,588,563
Ensembl chr13:80,278,770...80,588,594
G
Pik3r1
phosphoinositide-3-kinase regulatory subunit 1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of PIK3R1 mRNA
CTD
PMID:32076005
NCBI chr 2:32,878,942...32,963,668
Ensembl chr 2:32,882,032...32,963,631
G
Pik3r2
phosphoinositide-3-kinase regulatory subunit 2
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of PIK3R2 mRNA
CTD
PMID:32076005
NCBI chr16:18,665,517...18,674,067
Ensembl chr16:18,665,457...18,674,065
G
Pir
pirin
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of PIR mRNA
CTD
PMID:32076005
NCBI chr X:30,108,536...30,219,269
Ensembl chr X:30,108,538...30,219,218
G
Pitx1
paired-like homeodomain 1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of PITX1 mRNA
CTD
PMID:32076005
NCBI chr17:8,794,134...8,800,292
Ensembl chr17:8,794,134...8,800,291
G
Ppard
peroxisome proliferator-activated receptor delta
increases expression multiple interactions
ISO
antimonite results in increased expression of PPARD mRNA RTKI cpd inhibits the reaction [antimonite results in increased expression of PPARD mRNA]
CTD
PMID:17400267
NCBI chr20:6,298,785...6,363,970
Ensembl chr20:6,298,785...6,363,968
G
Prdx1
peroxiredoxin 1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of PRDX1 mRNA
CTD
PMID:32076005
NCBI chr 5:130,147,258...130,162,856
Ensembl chr 5:130,147,204...130,162,856
G
Serpine1
serpin family E member 1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of SERPINE1 mRNA
CTD
PMID:32076005
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
G
Slc2a3
solute carrier family 2 member 3
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of SLC2A3 mRNA
CTD
PMID:32076005
NCBI chr 4:155,960,944...156,026,000
Ensembl chr 4:155,960,946...156,025,472
G
Sod1
superoxide dismutase 1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of SOD1 mRNA
CTD
PMID:32076005
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
G
Sqstm1
sequestosome 1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of SQSTM1 mRNA
CTD
PMID:32076005
NCBI chr10:34,525,517...34,536,670
Ensembl chr10:34,525,519...34,536,673
G
Stat1
signal transducer and activator of transcription 1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] inhibits the reaction [OSM protein results in increased phosphorylation of STAT1 protein]; [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of STAT1 mRNA
CTD
PMID:32076005
NCBI chr 9:49,419,561...49,459,969
Ensembl chr 9:49,419,340...49,588,540
G
Sult1c3
sulfotransferase family 1C member 3
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of SULT1C3 mRNA
CTD
PMID:32076005
NCBI chr 9:7,221,580...7,266,991
Ensembl chr 9:7,221,578...7,267,030
G
Sult1e1
sulfotransferase family 1E member 1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of SULT1E1 mRNA
CTD
PMID:32076005
NCBI chr14:20,422,324...20,439,562
Ensembl chr14:20,422,324...20,439,275
G
Sult2b1
sulfotransferase family 2B member 1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of SULT2B1 mRNA
CTD
PMID:32076005
NCBI chr 1:96,200,155...96,261,295
Ensembl chr 1:96,200,156...96,261,295
G
Tgm1
transglutaminase 1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of TGM1 mRNA
CTD
PMID:32076005
NCBI chr15:29,191,039...29,206,000
Ensembl chr15:29,191,041...29,204,523
G
Tp63
tumor protein p63
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of TP63 mRNA
CTD
PMID:32076005
NCBI chr11:74,838,858...75,049,764
Ensembl chr11:74,838,859...75,049,398
G
Tsc22d3
TSC22 domain family, member 3
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of TSC22D3 mRNA
CTD
PMID:32076005
NCBI chr X:104,217,898...104,277,886
Ensembl chr X:104,217,925...104,276,861
G
Txn1
thioredoxin 1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of TXN mRNA
CTD
PMID:32076005
NCBI chr 5:72,712,334...72,724,564
Ensembl chr 5:72,711,933...72,724,629
G
Txnrd1
thioredoxin reductase 1
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of TXNRD1 mRNA
CTD
PMID:32076005
NCBI chr 7:20,830,042...20,914,990
Ensembl chr 7:20,830,045...20,907,863
G
Ugt1a6
UDP glucuronosyltransferase family 1 member A6
multiple interactions
ISO
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of UGT1A6 mRNA
CTD
PMID:32076005
NCBI chr 9:88,747,213...88,808,465
Ensembl chr 9:88,713,184...88,808,465
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all